DHA May Prevent Bone Loss

April 26, 2006

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

WEST LAFAYETTE, Ind.--High consumption of DHA (docosahexaenoic acid) inhibited bone loss in an animal model of postmenopausal osteoporosis, according to new research published in The Journal of Nutritional Biochemistry (17, 4:282-89, 2006).

Researchers from Purdue University and Indiana University administered a high-polyunsaturated fatty acid (PUFA) diet with a ratio of omega-6s (n-6s) to omega-3s (n-3s) of 5-to-1, and a low-PUFA diet with a ratio of n-6 to n-3 PUFAs of 10-to-1, to ovariectomized (OVX) SpragueDawley rats for 12 weeks. Tests indicated the 5-to-1 ratio diet significantly elevated DHA levels in the periosteum, marrow, and cortical and trabecular bones of the femur. Dual-energy X-ray absorptiometry measurements of femur and tibia bone mineral content (BMC) and bone mineral density (BMD) showed high consumption of DHA inhibited bone loss among the animals. Rats fed a low-PUFA diet displayed the lowest overall serum concentrations of bone resorption biomarkers, whereas bone formation was lowest in animals administered a high-PUFA diet. Regardless of dietary PUFA content, DHA in the 5-to-1 ratio diet preserved rat femur BMC in the absence of estrogen.

The researchers concluded dietary ratio of n-6 to n-3 PUFAs and bone tissue concentration of DHA minimize femur bone loss as evidenced by higher BMC in OVX rats.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like